Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis

Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis – an ELTR study

Published:2024-08 Issue:8 Volume:6 Page:101100
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

van Hooff Maria C.^ORCID,de Veer Rozanne C.,Karam Vincent^ORCID,Adam Rene,Taimr Pavel^ORCID,Polak Wojciech G.^ORCID,Pashtoun Hasina^ORCID,Murad Sarwa Darwish^ORCID,Corpechot Christophe,Mirza Darius,Heneghan Michael,Lodge Peter^ORCID,Oniscu Gabriel C.,Thorburn Douglas^ORCID,Allison Michael^ORCID,Metselaar Herold J.,den Hoed Caroline M.^ORCID,van der Meer Adriaan J.^ORCID,Mirza Darius,Heneghan Michael,Lodge Peter,Oniscu Gabriel,Thorburn Douglas,Allison Michael,Pratschke Johann,Manas Derek,Bennet William,Line Pal-Dag,Hot Emir,Zieniewicz Krzysztof,Ericzon Bo Goran,Fronek Jiri,Klempnauer Jurgen L.,Rasmussen Allan,Romagnoli Renato,Nemec Petr,Nordin Arno,Paul Andreas,De Simone Paolo,Porte R.J.,Berlakovich Gabriela,Cherqui Daniel,Pirenne Jacques,Sokal Etienne,Rossi Giorgio,Candinas Daniel,Bachellier Philippe,Rummo Oleg,Boudjema Karim,Mrzljak Anna,Soubrane Olivier,Metselaar Herold,Schneeberger Stefan,Navarro Francis,Berney Thierry,Duvoux Christophe,Colledan Michele,De Carlis Luciano,Boillot Olivier,Hardwigsen Jean,Pruvot Francois Rene,Suc Bertrand,Vivarelli Marco,Clavien Pierre Alain,Lang Hauke,Kosieradzki Maciej,Berrevoet Frederik,Heyd Bruno,Cescon Matteo,Chiche Laurence,Kochs Eberhard,Baccarani Umberto,Detry Olivier,Bartels Michael,Rossi Massimo,Soubrane Olivier,Scatton Olivier,Papanikolaou Vasileios,Alwayn Ian,Schemmer Peter,Senninger N.,Ducerf Christian,Di Benedetto Fabrizio,Tisone Giuseppe,Nadalin Silvio,Mathe Zoltan,Ribnikar Marija,Settmacher Utz,Becker Thomas,Silva Nuno,Daniel Jorge,Popescu Irinel,Lucidi Valerio,Bechstein Wolf O.,Decaens Thomas,Gugenheim Jean,Gruttadauria Salvatore,Zamboni Frausto,Zeytunlu Murat,Kalff Jorg C.,Vali Toomas,Tokat Yaman,Klar Ernst,Kochs Eberhard,Romagnoli Renato,Janek Julius,Kilic Murat,Katzarov Krum,Fisher Lutz,Buc Emmanuel,Castagneto Marco,Unek Tarkan,Spassov Lubomir,Stippel Dirk,Bruns Christiane,Schlitt Hans,Salame Ephrem,Kalicinski Piotr,Acarli Koray

Funder

Astellas Pharma US

Novartis

Publisher

Elsevier BV

Reference49 articles.

1. Primary biliary cirrhosis;Carey;Lancet,2015

2. Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases;Lindor;Hepatology,2019

3. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis;Poupon;Gastroenterology,1997

4. Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis;Poupon;J Hepatol,2003

5. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis;Harms;J Hepatol,2019